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The correct levels of deoxyribonucleotide triphosphates and their relative abundance are important to maintain
genomic integrity. Ribonucleotide reductase (RNR) regulation is complex and multifaceted. RNR is regulated
allosterically by two nucleotide-binding sites, by transcriptional control, and by small inhibitory proteins that
associate with the R1 catalytic subunit. In addition, the subcellular localization of the R2 subunit is regulated
through the cell cycle and in response to DNA damage. We show that the fission yeast small RNR inhibitor Spd1
is intrinsically disordered and regulates R2 nuclear import, as predicted by its relationship to Saccharomyces
cerevisiae Dif1. We demonstrate that Spd1 can interact with both R1 and R2, and show that the major restraint of
RNR in vivo by Spd1 is unrelated to R2 subcellular localization. Finally, we identify a new behavior for RNR
complexes that potentially provides yet another mechanism to regulate dNTP synthesis via modulation of RNR
complex architecture.
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Faithful DNA replication, a prerequisite for maintaining
genome integrity, requires the maintenance of the correct
concentration and the relative ratios of dNTPs (Chabes
et al. 2003; Holmberg et al. 2005). dNTPs are formed by
ribonucleotide reductase (RNR), which converts ribonu-
cleoside diphosphates into their deoxy forms. Eukaryotes
use type Ia RNR complexes comprised of multimers of two
subunits: the large (R1) catalytic subunit, and the small
(R2) diferric-tyrosyl radical-generating subunit (Stubbe
2003; Nordlund and Reichard 2006). Distinctive for type
Ia RNR complexes are two allosteric nucleotide-binding
sites on R1 (Reichard 2002; Nordlund and Reichard 2006).
The N-terminal ‘‘overall activity’’ site is an ATP cone do-
main that binds either ATP (stimulatory) or dATP (in-
hibitory). The specificity site can bind ATP, dATP, dTTP,
or dGTP and selects the substrate to be reduced, thus
maintaining the appropriate dNTP ratios (Nordlund and
Reichard 2006).
RNR is also regulated by a number of further mecha-
nisms. In all eukaryotes studied, RNR protein levels are
regulated via transcription. This is particularly obvious in
response to genotoxic stress, when DNA repair synthesis
requires dNTPs to be present outside of S phase. Work in
the budding yeast Saccharomyces cerevisiae identified
a further layer of control via the binding of a small RNR
inhibitor protein, Sml1, to the R1 subunit (Zhao et al.
1998, 2000; Chabes et al. 1999). Sml1 is degraded as cells
enter S phase and in response to genotoxic stress outside
of S phase (Zhao et al. 2001). Work in the fission yeast
Schizosaccharomyces pombe (Liu et al. 2003) demon-
strated that the R2 subunit is localized primarily to the
nucleus in non-S-phase cells, and is relocalized to the
cytoplasm in response either to S-phase entry or follow-
ing DNA damage checkpoint activation. Because the
majority of the R1 subunit is constitutively cytoplasmic,
this relocalization was proposed to promote RNR
complex formation and dNTP synthesis. R2 nuclear
localization depends on a small RNR regulator, Spd1. In
S. cerevisiae, an Spd1-related protein, Dif1, was subse-
quently shown to promote R2 nuclear import (Lee et al.
2008; Wu and Huang 2008). In cooperation with a nuclear
anchor, Wtm1 (Lee and Elledge 2006), Dif1-dependent
import results in R2 nuclear accumulation. R2 nuclear
accumulation is regulated by S-phase-dependent or geno-
toxic stress-dependent Dif1 degradation. The reduced
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Dif1 level decreases nuclear import while nuclear export
remains active, promoting a net increase in cytoplasmic
R2 (Lee et al. 2008).
S. cerevisiae Sml1 and Dif1 proteins share a domain,
the SML box (Fig. 1A; Lee et al. 2008). Synteny analysis
suggests that the SML1 and DIF1 genes are derived from
the same ancestral locus, diverging when S. cerevisiae
underwent genome duplication during its evolution. The
SML1 locus subsequently underwent a further direct
duplication event so that a related gene, HUG1, is imme-
diately adjacent (Lee et al. 2008). Hug1 andDif1 also share
a sequence motif, the HUG box, that is not apparent in
Sml1. Hug1 function is not well defined; its transcript is
induced by DNA damage, and it has been proposed to
regulate RNR feedback inhibition (Basrai et al. 1999;
Benton et al. 2006).
Spd1 in S. pombe and Dif1 in S. cerevisiae regulate R2
nuclear localization. The HUG domain is conserved
between Spd1 and Dif1. Dif1 binds R2 via the HUG
domain (Lee et al. 2008) to facilitate R2 nuclear import,
suggesting that Spd1 may share this function. Spd1 also
shares a region of sequence similarity with Sml1, equat-
ing to the last half of the suggested Sml1 RNR1-binding
domain (Zhao et al. 2000; Lee et al. 2008). This region
resides downstream from the C-terminal a-helix region of
Sml1, a region with a clear role in RNR1 inhibition (Zhao
et al. 2000). Conservation of an R1 interface, albeit
limited, would be consistent with the direct association
between Spd1 and Cdc22R1 reported to mediate vitro
biochemical inhibition of RNR (Hakansson et al. 2006).
The sequence conservation between Spd1, Dif1, Sml1,
and Hug1 indicates that Spd1 may be the sole S. pombe
ortholog of the ancestral gene (summarized in Fig. 1).
Here we provide evidence that Spd1 is an intrinsically
disordered protein (IDP) that acts as an import factor for
the RNR R2 subunit. Using FRET analysis, we demon-
strate that Spd1 controls RNR complex architecture.
However, this does not correlate to the formation of
active complexes. We suggest it reflects an additional
level of RNR regulation beyond formation of canonical
RNR tetramers of 2xR1 and 2xR2 subunits (a2b2 tetra-
mer). By structure–function analysis, we separate three
roles for Spd1: We identify a mutant defective specifically
for Suc22R2 nuclear import (spd1-M2), mutants specifi-
cally defective in their ability to restrain RNR function in
vivo (i.e., spd1-M12 and spd-M35), and mutants that have
specifically lost the ability to promote FRET (i.e., spd1-
M1 and spd1-M6). Thus, each of these three roles can be
separated from each other, underlining the segmental
distribution of function typical of IDPs. Contrary to
expectation, we show that the ability of Spd1 to restrain
RNR activity in vivo (and thus interfere with S phase) is
Figure 1. Spd1 is an intrinsically unfolded protein.
(A, top) Cartoon representation of relationship to S.
cerevisiae Dif1, Sml1, and Hug1 (data adapted from
Lee et al. 2008). (Bottom) Disorder and structure
predictions from the indicated software. (Red boxes)
Coil; (green boxes) helix. (B) Spd1 was purified to
homogeneity and showed a lower electrophoretic
mobility than expected (18 kDa vs. 14 kDa). Lane 2
(fraction 6) and lane 3 (fractions 7 and 8) of the
MonoQ purification after buffer change to PBS (pH
7.4). (Lane 1) Low-molecular-weight markers; mo-
lecular weight is indicated in kilodaltons. (C) A far-
UV CD spectrum of Spd1 recorded from 250 to 190
nm on 10 mM Spd1 and 10 mMNaH2PO4 (pH 7.4). A
large negative ellipticity with a maximum at 199 nm
suggests an unfolded protein with little or no sec-
ondary structure. (D) An 15N,1H-HSQC NMR spec-
trum of 1.0 mM 15N-Spd1 and 10 mM NaH2PO4 (pH
7.4) recorded at 10°C. Very little dispersion of signals
is seen, as well as variable peak intensities.
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not a consequence of its ability to sequester Suc22R2 in
the nucleus. The restraint of RNR activity in vivo likely
reflects the in vitro inhibition of RNR by Spd1 identified
by biochemical analysis, although this remains to be
established formally.
Results
Spd1 is an IDP
Sml1 is a member of a group of proteins that are in-
trinsically disordered (Danielsson et al. 2008). An IDP
lacks a well-structured three-dimensional fold (Tompa
2002). However, nuclear magnetic resonance (NMR)
studies show that IDPs can adopt transient structure in
solution, and that some IDPs fold onto their interaction
partner when they associate. This process, coupled fold-
ing and binding, can result in protein–protein interactions
with relatively low affinity but high specificity (Sugase
et al. 2007). The Spd1 sequence has the typical charac-
teristics of an IDP: a high content of charged residues
(23%), and a low aliphatic index (52.85; for reference,
myoglobin = 95.1). Structural prediction programs such as
DrDOS (Ishida and Kinoshita 2007) predict a high proba-
bility of disorder, with minor regions that can potentially
form intermittent secondary structures. Most consistent
are the two helical regions between residues 27–44 and 66–
76, plus the possibility of shorter, extended structures
between 6–10 and 115–120 (Fig. 1A).
To investigate the disorder characteristics by spectros-
copy, recombinant Spd1 was purified to >98% homoge-
neity (Fig. 1B). Electrophoretic mobility corresponded to
;18 kDa, higher than the expected 14.2 kDa. This is a
general attribute of IDPs (Tompa 2002). A far-UV CD
spectrum showed no distinct signs of pronounced sec-
ondary structure elements, with very little negative
ellipticity in the 210- to 220-nm range (Fig. 1C). Instead,
a large negative signal with maximum at 199 nm was
evident, highly indicative of an unfolded protein. An
15N,1H- HSQC NMR spectrum recorded at 10°C showed
a very narrow distribution of signals in the 1H dimension,
also typical of unfolded proteins (Fig. 1D). Importantly,
a distribution of both high and low intensities of the
NMR signals was observed, which suggests some resi-
dues of Spd1 are in intermediate exchange on the NMR
time scale, possibly due to sampling of several conforma-
tions. Thus, Spd1 possesses all of the hallmarks of an IDP:
low electrophoretic mobility, a lack of secondary struc-
ture in far-UV CD, and a collapsed NMR spectrum
corresponding to an unfolded protein. Similar results
have been established previously for Sml1 (Danielsson
et al. 2008).
Spd1 regulates R2 nuclear import, but does not act
as a nuclear anchor
In S. cerevisiae, two distinct mechanisms contribute to
nuclear accumulation of R2: Dif1-dependent nuclear
import, and R2 retention by the Wtm1 nuclear anchor.
To establish if Spd1 shares the nuclear import function,
we examined if Suc22R2 accumulates in the nucleus in
spd1-d cells by blocking nuclear export with leptomycin
B (LMB), which inhibits Crm1-dependent nuclear export
of Suc22R2 (Liu et al. 2003). Suc22R2 did not accumulate
in the nucleus in response to LMB treatment (Fig. 2A),
indicating that Suc22R2 is no longer transported into the
nucleus in the absence of Spd1 and thus cannot accumu-
late there when export is blocked.
Despite considerable effort, we did not identify a ho-
molog or ortholog of the Wtm1 nuclear anchor mecha-
nism in S. pombe. In addition, spd1 deletion results in
complete Suc22R2 delocalization from the nucleus. In
S. cerevisiae, Dif1 deletion only partially disrupts R2
nuclear accumulation. The remaining accumulation is
Wtm1-dependent (Lee and Elledge 2006). This suggests
there is no nuclear anchor for Suc22R2 in S. pombe, but it
remains formally possible that Spd1 both contributes to
Suc22R2 nuclear import and acts as a canonical Suc22R2
nuclear anchor. If so, forced Spd1 localization to the
nucleolus would be predicted to result in concomitant
nucleolar Suc22R2. We thus modified the spd1+ locus to
express a C-terminal fusion of 13-Myc epitopes followed
by the Fib1 fibrillarin-like protein that is known
to localize to the nucleolus (Gallagher et al. 1993).
The fusion protein (Fig. 2B) expressed by the spd1 pro-
moter retained function, as judged by the correct profile
and dynamics of Suc22R2 localization (Fig. 2C; data
not shown). In a GFP-Suc22R2 background, we observed
that Spd1-13Myc-Fib1 localized to the nucleolus, but
Suc22R2 was not enriched in the nucleolus when com-
pared with spd1+ controls (Fig. 2C). Thus, Spd1 shares
a nuclear import function with Dif1, but does not
contribute to nuclear retention via a nuclear anchor
function.
Spd1 is required for FRET between Cdc22R1
and Suc22R2
The increased colocalization of R1 and R2 subunits in
the cytoplasm during S phase and in response to geno-
toxic stress is proposed to allow active RNR complexes to
form when dNTPs are required (Liu et al. 2003, 2005;
Holmberg et al. 2005; Zhang et al. 2006; Wu and Huang
2008). To explore this possibility, we established a FRET
assay (Fig. 3A,B) to examine the Cdc22R1/Suc22R2 inter-
action. First, we used the fluorescent protein tags to es-
timate the relative abundance of Cdc22R1 and Suc22R2 in
both the nuclear and cytoplasmic compartments in G2-
and S-phase cells. The relative fluorescence between
Cdc22R1 and Suc22R2 is 3:1 (data not shown). In G2 phase,
Suc22R2 fluorescence was approximately threefold more
intense in the nucleus than the cytoplasm, with ;74% of
the signal residing in the nucleus (Fig. 3C). In S phase,
nuclear Suc22R2 fluorescence is partitioned between two
nuclei and comprises ;26.5% of the GFP-Suc22R2 signal.
Individually, each nucleus shows a significant loss of in-
tensity comparedwithG2 phase.We also see a correspond-
ing gain in intensity (from 26% to 63.5%) in the cytoplasm
(Fig. 3C).
In spd1+ cells, FRET could be detected in the cyto-
plasm and the nucleus of cells in both G2 and S phase
Spd1 inhibition of RNR
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(Fig. 3D). In this case, FRET was used simply as an
indicator of the R1–R2 interaction and not as a quantita-
tive measure of association number or structural prox-
imity. Surprisingly, in spd1-d cells, we did not detect
FRET in the cytoplasm or nucleus of either S-phase or G2
cells (Fig. 3E). Treating spd1+ cells with hydroxyurea
(HU), an agent that inhibits RNR and synchronizes cells
in S phase, resulted in the FRET signal disappearing
(Fig. 3E). However, FRET was similarly lost when
cdc25-22 cells synchronized in G2 were held in G2 and
treated with HU (data not shown), indicating an S-phase-
independent effect of HU. Taken together, these data
indicate that Spd1 affects the association of Cdc22R1/
Suc22R2 subunits, but that this does not correlate with
apparent activation of RNR.
Alanine scanning mutagenesis of Spd1
From the available data, we can postulate three possible
in vivo functions for Spd1: regulation of Suc22R2 nuclear
import, an influence on RNR complex architecture that
equates to our FRET analysis, and, finally, an in vivo
restraint of RNR activity that correlates with an in-
creased dNTP concentration in the absence of Spd1 in
csn1-d and ddb1-d cells (Holmberg et al. 2005) and is
possibly equivalent to either the inhibition observed in
vitro (Hakansson et al. 2006), the nuclear sequestration of
Suc22R2, or a combination of both. To understand how
these potential functions relate to each other, and to shed
light on the mechanism by which Spd1 inhibits RNR, we
created 41 independent spd1 mutants in which each
Figure 2. Spd1 regulates Suc22R2 nuclear
import. (A) spd1+ CFP-suc22 and spd1-d
CFP-suc22 cultures were treated with HU
(20 mM) to arrest cells in S phase and/
or leptomycin (100 ng/mL) to block nu-
clear export. After 2 h, cells were formal-
dehyde-fixed, and GFP was visualized by
epifluorescence and DNA was visualized
by DAPI staining. In spd1+ cells treated
with HU, Suc22R2 becomes pan-cellular.
(Bottom left) Concomitant treatment with
leptomycin prevents nuclear export and
Suc22R2 redistribution. (Bottom right) In
the absence of Spd1, GFP-Suc22 is distrib-
uted throughout the cell and does not
accumulate in the nucleus when nuclear
export is blocked. (B) Cartoon representa-
tion of the spd1-Myc and spd1-Myc-Fib1
constructs integrated at the spd1 locus
under control of the spd1 promoter. A
53 glycine linker (5G) separates Spd1 from
the tags. (C) GFP-Suc22 (epifluorescence),
DAPI-stained DNA, and the Myc epitope
(indirect immunofluorescence) visualized
in fixed cells following logarithmic
growth. (D) Merged images of Myc and
GFP-Suc22 localization from the spd1-
Myc-Fib1 culture. White arrows indicate
example Myc staining nucleoli. Bars, 5 mm.
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sequential group of three residues were substituted for
alanine (Fig. 4A), and examined their influence on Spd1
degradation and Spd1-dependent phenotypes.
Analysis of Spd1 degradation in vitro and in vivo
We established an in vitro assay for Spd1 degradation by
incubating 35S methionine-labeled Spd1 in whole-cell
extract. Degradation kinetics were monitored by SDS-
PAGE and autoradiography (Fig. 4B). Degradation was
dependent on the Cullin 4 E3 ubiquitin ligase Pcu4–
Ddb1Cdt2 and the signalosome, as predicted (Liu et al.
2003). Each individual mutant protein (Fig. 4C) was 35S
methionine-labeled and incubated with degradation-
competent extract, and the percentage of protein remain-
ing after 10 and 20 min was quantified. The results did
not identify a domain responsible for degradation, but did
reveal a single stable mutant, Spd1-M14. Deconvolution
of this mutant into the three individual alanine sub-
stitutions revealed that a single lysine residue (K42) was
required for efficient degradation (Fig. 4D).
We were surprised not to define a degron domain, and
were also wary of the observation that a single lysine is
required: Usually, disrupting a single lysine residue in
vivo results in adjacent lysines acting as alternative
ubiquitin acceptor sites. We thus integrated each mutant
into the spd1 locus, where they are expressed under
control of the spd1 promoter. To assay degradation, each
strain was grown to logarithmic phase and treated with
20 mM HU. This induces the Cdt2 targeting subunit of
Cul4–Ddb1Cdt2 ubiquitin ligase and promotes Spd1 deg-
radation (Liu et al. 2005). Samples for Western blot
analysis were prepared immediately before HU addition
and at 1, 2, and 4 h. Again we did not define a specific
domain controlling Spd1 degradation (Fig. 4E). The Spd1-
M14 and Spd1-K42A mutant proteins identified in the in
vitro studies also showed no evidence of stability (Fig. 4E;
data not shown). There were several additional observa-
tions. First, a double mutant encompassing the two
checkpoint kinase consensus sites, Spd1-M(3 + 18), was
not stabilized (Fig. 4F). Second, the initial protein levels of
many mutants varied significantly. This is a reproducible
observation seen with two independent a-Spd1 anti-
bodies, and likely reflects that triple alanine substitution
in an IDP is expected to affect intrinsic stability. Third,
only two mutant proteins, Spd1-M21 and Spd1-M23,
were significantly stabilized.
Separation of Suc22R2 localization and RNR
inhibitory regulation
We crossed each spd1 mutant into the GFP-suc22 back-
ground and observed Suc22R2 localization by direct
fluorescence in untreated cells and cells exposed to 20
mMHU for 4 h (Fig. 5). In spd1+ cells, Suc22R2 was largely
nuclear (most asynchronous S. pombe cells are in G2).
Figure 3. Spd1 is required for FRET between Cdc22R1 and Suc22R2. (A) Cartoon representation of FRET between CFP- and YFP-tagged
RNR subunits. Bleaching the YFP acceptor results in an increased emission signal from the CFP donor. The green circle represents the
nucleus (Suc22R2 accumulates in the nucleus). Squares represent the bleached area; in this instance, a region of cytoplasm. (B)
Equivalent cartoon showing result when fluorophores are not sufficiently aligned for FRET. Notice that, instead of an increase in the
signal from the donor (i.e., evidence of FRET), a moderate decrease is seen (as opposed to no change) due to some overlap in the
absorption spectra for CFP and YFP. (C) Percentage of nuclear and cytoplasmic fluorescent intensity of Cdc22-CFP and CFP-Suc22 in
single tagged cells visualized under the same microscope slide. (D) Representative images from spd1+ and spd1-d cultures without
treatment with HU. (E) Quantification of combined nuclear and cytoplasmic FRET signal. Error bars, SD from mean. Negative FRET
(formally no-FRET) results from nominal photobleaching of the donor along with the acceptor.
Spd1 inhibition of RNR
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Following HU treatment (cells arrested in S phase; Spd1-
degraded), ;20% of cells retained weak nuclear GFP
fluorescence, and Suc22R2 became pan-cellular in the
remaining ;80%. spd1-m2, spd1-m14, and spd1-m26
were fully defective for Suc22R2 nuclear accumulation.
A small but notable effect on nuclear accumulation was
observed for spd1-m34, spd1-m35, and spd1-m36. Four
mutants—spd1-m11, spd1-m12, spd1-m13, and spd1-
m33—showed more dramatic loss of Suc22R2 nuclear
accumulation upon HU treatment compared with spd1+
cells. Finally, four mutants—spd1-m21, spd1m-38, spd1-
m40, and spd1-m41—displayed robust Suc22R2 nuclear
accumulation poorly reversed by HU treatment. No
mutant showed a complete inability to delocalize
Suc22R2 to the cytoplasm (the phenotype seen when
Spd1 is completely stable; i.e., in pcu4-d, cdt2-d, and
csn1-d mutants). Notably, the region that corresponds to
the conserved HUG domain (spd1-m10 through spd1-
m20) was particularly sensitive to mutation in the assay
for nuclear localization. In Dif1, this domain is proposed
to bind the R2 subunit and promote its nuclear import.
If the mechanisms by which Spd1 restrains RNR
function in vivo depend on its ability to localize Suc22R2
in the nucleus, then RNR activation would be at least
partially dependent on the loss of nuclear Suc22R2 accumu-
lation in S phase, and spd1 mutants unable to accumulate
Figure 4. Stability of Spd1 mutant pro-
teins. (A) The 41 mutants of spd1 created.
These are designated as spd1-M1, spd1-
M2, etc. Each mutant results in the three
indicated amino acids being changed to
alanine. Bold indicates conserved HUG
and R1 domains (see Fig. 1A). (B) In vitro
degradation of 35S-labeled Spd1. In vitro
translated Spd1 is incubated for the in-
dicated number of minutes with whole-
cell extract derived from either wild type
(Wt) or the indicated mutants.mts3-ts and
mts2-1 are mutations in genes encoding
subunits of the proteasome and show
compromised degradation in this assay.
As is seen in vivo, Spd1 degradation is
dependent on the signalosome subunits
Csn1 and Csn2, and on the Cullin 4
homolog Pcu4. (C) Quantification of in
vitro degradation assay for the individual
mutants. (Blue symbols and dashed line)
10-min incubation; (red symbols and solid
line) 20-min incubation. (D) The three
amino acids mutated in spd1-M14 were
changed individually to alanine and tested
for stability in wild-type cell extract. Both
bands are Spd1-specific. (E) In vivo stabil-
ity of Spd1 mutant proteins. Each mutant
was integrated separately at the spd1 ge-
nomic locus under control of the spd1
promoter. Logarithmically growing cells
were incubated with HU (20 mM) for 1,
2, and 4 h; extract was prepared and sub-
jected to SDS-PAGE; and Spd1 was de-
tected by Western analysis with polyclonal
a-Spd1 antisera. A white star marks the
Spd1-specific bands. Before each mutant, a
control lane contains extract from spd1-d
cells. Blots were probed in parallel for
Cdc2 as a loading control. (F) Identical
analysis of spd1-M3, spd1-M18, and the
combined spd1-M3-18 mutations that
cover the two conserved Cds1Chk2 kinase
consensus sites.
Nestoras et al.
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Suc22R2 in the nucleus should phenocopy the spd1-d
null. We thus tested two robust phenotypes for Spd1-
dependent restraint of RNR activity. The first is the
ability of spd1-null mutants to suppress the synthetic
inviability associated with concomitant loss of the csn1
signalosome component and the rad3 checkpoint gene
(Liu et al. 2003). Essentially, in csn1-d mutants, Spd1 is
stable, and thus RNR activity is restrained in S phase—a
situation reminiscent of the inviability ofMEC1 deletion
and the ability of SML1 deletion to suppress this (Zhao
et al. 1998). Mutants in the HUG domain—plus spd1-
m26, spd1-M34, spd1-M35, and spd1-M41—rescued rad3-
d csn1-d synthetic lethality with significant efficiency, in
many cases approaching that of the spd1-d null (Fig. 6A).
The second assay we chose is the ability of spd1
deletion to rescue the spore formation defect evident in
the ddb1-d background (Liu et al. 2003; Holmberg et al.
2005). Ddb1 is a component of the Pcu4–Ddb1Cdt2 ubiq-
uitin ligase required for Spd1 degradation, so Spd1 re-
strains RNR activity in S phase and lowers dNTP pools in
ddb1-d mutants, and thus they cannot progress through
meiosis and form spores. This phenotype and the low
dNTP pools are reversed by deleting spd1. We combined
each of the 41 spd1 mutants with h90 ddb1-d and scored
the percentage of asci with either zero, one, two, three, or
four spores (Fig. 6B). Spore formation was restored (>70%
four-spored asci, close to that of ddb1-d spd1-d double-
null cells: >90%) in mutants spd1-m11 through spd1-
m16, spd1-m18, spd1-m19, spd1-m26, spd1-m34 through
spd1-m38, and spd1-m41.
Both of these assays are robust and semiquantitative
(Liu et al. 2003; Holmberg et al. 2005). Taking them
together, we conclude that the defect in Suc22R2 nuclear
import does not correlate with the biological evidence for
restraint of RNR activity. Of particular interest are
mutants spd1-m2 (import-defective, no defect in restrain-
ing RNR) and spd1-m10 plus spd1-m11 (little or no
import defect, but significantly unable to restrain RNR
activity). The broader trends in the data make clear that
HUG domain mutations (spd1-m10 through spd1-m20)
influence both import and restraint. Mutations in the
C-terminal region (spd1-m34 through spd1-m41) also
influence both import and restraint, and likely define
a new segment of Spd1.We suggest this is named the Spd1
domain, in keeping with the nomenclature of Lee et al.
(2008). Finally, mutations within the putative R1-binding
region (of which only three residues are identical between
Sml1 and Spd1) do not appear to dramatically influence
Figure 5. Subcellular localization of Suc22R2 in the individual spd1mutants. (A) GFP-Suc22 was visualized by epifluorescence in fixed
untreated cells and cells treated for 4 h with HU (20 mM) before fixation to arrest S phase. Controls were spd1+ (+) and spd1-d (). These
are shown on the left. The majority of spd1+ cells show nuclear GFP-Suc22. Following incubation in HU, no evidence of nuclear
accumulation of GFP-Suc22 is seen in >80% of cells, the signal being pan-cellular. In the absence of Spd1, nuclear accumulation is not
seen in either untreated or treated cells. (B) A representative image: spd1-M14 behaves like a null mutant of spd1 in this assay. GFP-
Suc22 was visualized in spd1-M14 cells without HU treatment. DNA was visualized by DAPI staining. Error bars, SD from mean.
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Figure 6. Ability of individual spd1 mutants to restrain RNR function in vivo. Two in vivo assays for RNR function are shown. (A)
The ability of spd1 mutants to rescue the synthetic lethality of a rad3-ts csn1-d double mutant at 34°C. A dilution series for each
mutant was spotted, and plates were incubated at 34°C (partial loss of checkpoint). Viability is a semiquantitative measure of the loss of
the in vivo inhibitory function of Spd1 (Liu et al. 2003). (B) The ability of spd1 mutants to rescue the spore formation defect of
homothalic/h90 ddb1-d mutants. The number of spores formed gives a semiquantitative measure of the loss of the in vivo inhibitory
function (Holmberg et al. 2005). The in vivo dATP concentration relative to ddb1-d cells were measured in selected mutants and are
given above. Loss of inhibitory function correlates with increased dNTP pools. Wild-type (Wt) ddb1-d and ddb1-d spd1-d controls are
shown on the left.
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either import or restraint of RNR activity (spd1-m28
through spd1-m32).
The ability to promote R1–R2 FRET does not correlate
with RNR inhibition or nuclear import
Each of the 41 spd1mutants was crossed into the cdc22R1-
CFP YFP-Suc22R2 strain and tested for their ability to
promote Cdc22R1–Suc22R2 FRET. Only 12 of the 41
mutants could promote R1–R2 FRET (Fig. 7A). In most
of these 12 cases, the FRET signal was comparable with
that seen in spd1+ cells, and was seen in G2 and S phase in
both the nuclear and the cytoplasmic compartments
(Fig. 7B). The ability to promote R1–R2 FRET did not
correlate with either the Suc22R2 nuclear import function
of Spd1 or its ability to restrain RNR activity. For example,
spd1-M2 keeps the R1–R2 FRET signal but lacks the R2
nuclear localization function. Mutant spd1-M12 similarly
promotes R1–R2 FRET but has lost the ability to restrain
RNR activity. Mutants demonstrating the converse are
also apparent; i.e., spd1-M1 kept both the Suc22R2 nuclear
import function and the ability to restrain RNR activity,
but has lost the ability to promote FRET.
Spd1 can interact with both Cdc22R1 and Suc22R2
Active RNR in vitro consists of an a2b2 tetramer consist-
ing of 2xR1 and 2xR2 subunits (Nordlund and Reichard
2006). Since RNR is active in spd1-d cells, R1–R2 FRET
cannot simply reflect active tetramers. Furthermore,
R1–R2 FRET does not decrease when cells enter S phase,
so it is unlikely that the FRET signal reflects inactive
R1–R2 complexes. Both Escherichia coli (Rofougaran
et al. 2008) and mouse (Rofougaran et al. 2006) R1 sub-
units can be induced to form hexamers (a6) in vitro by
either dATP or ATP binding. These subsequently form
a6b2 octamers by association with a 2xR2 dimer (b2). a6b2
complexes have been suggested to represent the primary
active RNR form because sufficient ATP is available in
cells to occupy the majority of activity sites, and a corre-
lation has been observed between a6 hexamer formation
and ATP activation (Rofougaran et al. 2008). We used size
fractionation to establish whether the presence of Spd1
correlated with the presence of higher-order RNR com-
plexes (Fig. 8A). No evidence for multimer formation
was observed in either exponential spd1+ or spd1-d cells.
Limited higher-mass complexes were observed following
HU treatment, but these were not spd1-dependent. Thus,
we believe it unlikely that R1–R2 FRET reflects different
higher-order complex formation.
Despite extensive efforts, we were not able to identify
conditionswhere Spd1 can be coprecipitatedwithCdc22R1
or Suc22R2 from cell extracts. IDPs can bind multiple
substrates with high specificity but low affinity, which is
consistent with the low-affinity Spd1–Cdc22R2 interaction
Figure 7. Ability of the individual spd1 mutants to
promote Cdc22R1-Suc22R2 FRET. Each of the 41 in-
dividual mutants was crossed to the cdc22-YFP CFP-
suc22 background and tested for FRET signal. (A)
Summary of FRET intensities. FRET was examined in
both the nucleus and the cytoplasm of both mono-
nuclear (G2) and septating binucleate (S-phase) cells.
(Left) Controls are spd1+ and spd1-d. (B) The data for
each circumstance for the mutants able to promote
FRET. Error bars, SD from mean.
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reported (Hakansson et al. 2006). We thus used fluores-
cence quenching to establish if Spd1 could bind either R1
or R2 subunits (Fig. 8B). Recombinant Spd1 can interact
with both Cdc22R1 and Suc22R2 in vitro, as predicted by
Hakansson et al. (2006) and supported by our identification
of a role for Spd1 in Suc22R2 nuclear import.
Discussion
RNR dysregulation results in inappropriate total dNTP
levels and/or unbalanced dNTP ratios, which are changes
detrimental to genome stability (Chabes et al. 2003). RNR
subunit availability is regulated in most organisms via
transcriptional control (Elledge et al. 1993; Nordlund and
Reichard 2006). In the fission yeast, cdc22R1 and suc22R2
are induced transcriptionally at the transition between
G1 and S phase by the Cdc10, Res1, and Res2-containing
transcription factor MBF (Fernandez Sarabia et al. 1993).
In addition, DNA structure checkpoint activation results
in inhibition of the Nrm1 MBF corepressor and sub-
sequent MBF-dependent transcription (de Bruin et al.
2006). However, in cycling cells, the levels of Cdc22R1
Figure 8. Spd1 interacts with both Cdc22R1 and Suc22R2. (A) Gel filtration of extracts prepared from cdc22-CFP GFP-suc22 double-
tagged spd1+ and spd1-d cells after cross-linking with (right) and without (left) 4-h HU treatment. The a2b2 complex is predicted to be
274.6 kDa. Size markers are given above. (B) Fluorescence quenching assay for interaction between individual RNR subunits and Spd1.
(Far left) Fluorescence emission spectra of individual proteins. (Middle left) Suc22R2 + Spd1. Predicted additive fluorescence emission
(thin line) and experimental results (thick line) differ, demonstrating an interaction. (Middle right) Equivalent assay for Cdc22R1 + Spd1.
(Far right) Aliquots of purified proteins assessed by SDS-PAGE. (C) Summary of data. (From the top) Ability to promote FRET. The
region corresponding to the HUG and RNR interaction domains (see Fig. 1) are indicated. Where the mutant number is underlined,
FRET data have been verified by reversing the tags (i.e., cdc22-CFP YFP-suc22). The ability of spd1mutant cells to grow at 34°C in the
rad3-ts csn1-dmutant background. Growth is scored semiquantitatively from the data in Figure 6A and several repeats. Spore viability
data are reproduced from Figure 6B. Nuclear accumulation of Suc22R2 is reproduced from Figure 5A. The degradation of Spd1 in vivo is
semiquantitatively estimated (by eye) from the data in Figure 4E and several repeats for all mutants. Asterisks indicate those mutants
with partial (*) or complete (**) resistance to the in vitro degradation assay.
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and Suc22R2 protein do not change dramatically during
the cell cycle or after checkpoint activation (Watson et al.
2004). Most likely, transcriptional regulation ensures that
cells entering the cell cycle from stationary phase, or
those damaged during stationary phase, have a supply of
RNR subunits. A significant proportion of RNR regula-
tion in cycling cells thus occurs post-translationally.
The in vivo inhibitory function(s) of Spd1
In S. cerevisiae, the Sml1 inhibitor binds to the R1
subunit (Zhao et al. 2000; Zhang et al. 2007) and prevents
dNTP synthesis by inserting its C-terminal aromatic
residue into a cleft usually occupied by the C-terminal
residue of R2. Each S phase, Mec1 kinase activates the
downstream Dun1 kinase to promote Sml1 degradation
(Zhao and Rothstein 2002), likely by phosphorylating
serine residues within the Sml1 phospho-degron (SML
box) (see Fig. 1). When Mec1 is absent, Sml1 is not
degraded, and dNTP synthesis is inhibited during S phase.
Sincemec1mutants are also checkpoint-defective,MEC1
is an essential gene: A combination of low dNTP pools
and a checkpoint defect results in cell death. Concomi-
tant deletion of SML1 and MEC1 restores cell viability
because S phase is no longer inhibited and the checkpoint
thus is not required (Zhao et al. 2001).
Like S. cerevisiae Sml1, S. pombe Spd1 inhibits RNR in
vitro (Hakansson et al. 2006) and restrains RNR activity
in vivo when present in S phase (Liu et al. 2003).
Importantly, restraint of RNR activity did not correlate
with Suc22R2 relocalization. Both of the previously char-
acterized biological assays for in vivo RNR activity gave
consistent results and identified several mutants that
clearly separate the nuclear import role of Spd1 from its
ability to restrain RNR activity in vivo. Specifically, spd1-
M12 is unable to restrain RNR activity but is competent
for Suc22R2 nuclear import, while mutant spd1-M2 keeps
the ability to restrain RNR activity but is, as far as the
assay allows us to judge, fully defective for the nuclear
import function. The complementary specific loss of
function between these two mutants strongly suggests
that the major regulatory role of Spd1 on RNR activity is
not directly dependent on subcellular distribution of
RNR subunits. Most likely, the restraint of RNR activity
in vivo correlates with the in vitro inhibition via binding
to Cdc22R1 (Hakansson et al. 2006).
We can identify two specific regions of Spd1 that, when
mutated, result in decreased restraint of RNR. These two
regions are the HUG domain and an additional region, the
Spd1 domain, defined by mutants spd1-M34 through
spd1-M41. The HUG domain is required for both the
nuclear import function and the ability to restrain RNR
activity in vivo. This raises the possibility that Spd1
interacts with both R1 and R2 subunits in S. pombe
minimally through its HUG domain. We demonstrated
that Spd1 can indeed bind both Cdc22R1 and Suc22R2 in
vitro, but defining the mechanism of association awaits
further biophysical characterization, as the dual specific-
ity of Spd1 likely reflect the potential for low-affinity
interactions between IDPs and several substrates.
Spd1 functions to promote nuclear import but is not
a nuclear anchor
To establish if Spd1 shares the Dif1 function in nuclear
import, we explored whether blocking nuclear export in
spd1-deleted cells resulted in nuclear Suc22R2 accumula-
tion: The absence of nuclear export will result in Suc22R2
nuclear accumulation if import is active. In LMB-treated
spd1-d cells, Suc22R2 did not accumulate in the nucleus,
demonstrating that Spd1 is required for active Suc22R2
nuclear import. A cluster of the mutants analyzed (spd1-
M11 through spd1-M16) were either partially or com-
pletely defective for Suc22R2 import (data summarized in
Fig. 8C). This cluster largely encompasses the conserved
HUG domain, suggesting that, like for Dif1, the HUG
domain is important for nuclear import and likely defines
an R2 interaction surface, a prediction consistent with
our identification of a direct association between Suc22R2
and Spd1 in vitro. Two additional mutants, spd1-M2
and spd1-M26, also lost Suc22R2 nuclear accumulation
function.
In S. cerevisiae, loss of active import (DIF1 deletion)
results in decreased but not absent R2 nuclear accumu-
lation because the Wtm1-dependent nuclear anchor re-
tains R2 subunits (Lee and Elledge 2006). Loss of both
Dif1 (active import) and Wtm1 (anchoring) is required for
complete loss of R2 nuclear accumulation. In S. pombe,
loss of Spd1 alone results in complete loss of Suc22R2
nuclear accumulation. Either there is no R2 nuclear
anchor in S. pombe, or Spd1 itself fulfils both import
and anchoring roles. However, when Spd1 is localized
artificially to the nucleolus, we did not detect additional
Suc22R2 in the nucleolus, implying that there is no
nuclear anchor for Suc22R2.
Alanine scanning mutagenesis did not define
a degron domain
In S. cerevisiae, the SML box of the Sml1 and Dif1
proteins is thought to define a phospho-degron targeted
by Mec1ATR-dependent Dun1 kinase activity. In
S. pombe, Spd1 degradation is independent of Rad3ATR
and the downstream kinase Cds1Chk2 during S phase.
While Spd1 degradation becomes dependent on both
kinases in response to checkpoint activation, this de-
pendency is known, at least in part, to reflect the
checkpoint dependence of cdt2 transcript induction.
cdt2 encodes the adaptor for the ubiquitin ligase Pcu4–
Ddb1Cdt2 that targets Spd1 for degradation. We did not
define a distinct domain required for Spd1 degradation.
This is consistent with the lack of evidence for regulation
of Spd1 degradation by phosphorylation (Liu et al. 2005).
Furthermore, no single serine or threonine mutation
prevented degradation. There are no consensus Rad3ATR
sites on Spd1, but two potential Cds1Chk2 sites are
evident. Mutating both of these sites individually (spd1-
M3 and spd1-M18) or together (spd1-M3–18) did not affect
Spd1 stability.
Four mutants—spd1-M21, spd1-M23, spd1-M40, and
spd1-M41—were partially resistant to degradation. Cells
expressing these partially stable proteins were less
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responsive to loss of nuclear accumulation of Suc22R2
following HU, but none were synthetically lethal with
rad3-ts (data not shown). This indicates that, unlike
indirect stabilization of Spd1 via deletion of E3 ligase
components, these mutant proteins did not keep their
ability to fully restrain RNR activity. Intriguingly, the in
vitro degradation assay identified a single lysine required
for Cul4–Ddb1Cdt2 and signalosome-dependent E3 ubiq-
uitin ligase degradation of Spd1. However, mutating this
residue made no difference to in vivo Spd1 stability. One
possibility is that K42 is the sole Ub acceptor in vitro, but
is likely substituted by other lysines in vivo.
A novel Spd1-dependent level of RNR regulation?
Since we and others have speculated previously that
active RNR complexes are formed in the cytoplasm after
colocalization of Cdc22R1 and Suc22R2 following Spd1
degradation, we established a FRETassay to examine R1–
R2 association in different cellular compartments. Our
assumption was that 2xR1–2xR2 tetramer formation
(a2b2 complex) would be enhanced in the cytoplasm
following Spd1 degradation. While we could clearly
visualize FRET between Cdc22-YFP and CFP-Suc22
(and similarly when the tags were reversed) (data not
shown), R1–R2 FRETwas not enhanced upon loss of Spd1,
but was instead completely Spd1-dependent and did not
correlate with RNR activity: It was neither increased nor
decreased in the cytoplasm of S-phase cells compared
with G2 cells. R1–R2 FRET also disappeared when spd1+
cells were treated with HU. However, spd1+ cells held in
G2 and treated with HU lost the FRET signal within 30
min (data not shown), despite not progressing into
S phase, indicating that HU, a free-radical scavenger,
may independently quench the FRET signal.
Of the 41 spd1mutants tested for R1–R2 FRET, 12 were
positive. While there was some variation in the intensity
of the FRET signal in these mutants, this was modest,
relatively evenly distributed between the nuclear and
cytoplasmic compartments, and not specifically different
for either G2- or S-phase cells. Interestingly, the distribu-
tion of the mutants able to FRET did not correlate with
either the nuclear import role or the in vivo restraint of
RNR activity. For example, spd1-M2 cells were FRET-
competent and had lost nuclear import completely, while
spd1-M12 cells were FRET-competent but were unable to
restrain RNR activity.
What does the FRET signal represent? In vitro, active
RNR complexes consist of 2xR1 and 2xR2 subunits
(a2b2). Both ATP (activating) and dATP (inhibitory) bind-
ing to the allosteric overall activity site stimulate a2b2
formation, despite their opposite effects on activation.
Our gel filtration data indicate the presence of R1–R2
complexes at the size expected for a2b2 complexes and
show that these were not dependent on spd1+. Combined
with the observation that Spd1 loss leads to RNR activa-
tion, we can conclude that the presence of active a2b2
tetramers cannot be the cause of the FRET signal. Recent
work using both E. coli (Rofougaran et al. 2008) andmouse
(Rofougaran et al. 2006) RNR proteins has suggested that
both dATP and ATP induce the formation of R1 hexamers
(a6) that can form an a6b2 octamer by association with
a dimer (b2) of R2 subunits. However, by gel filtration
analysis, we did not observe evidence for Spd1-dependent
higher-order RNR complexes. A subfraction of Cdc22R1
and Suc22R2 were seen to migrate at higher molecular
weight, but this occurred after treatmentwith HU andwas
independent of spd1 status.
Our data suggest that Spd1-dependent FRET between
R1 and R2 subunits reflects a changed conformation of the
RNR a2b2 complex. We hypothesize that Spd1 mediates
formation of immature inactive RNR complexes. In these
inactive complexes, the fluorophores are appropriately
aligned to allow FRET between Cdc22R1 and Suc22R1,
reflecting an optimal complex architecture for subsequent
activation when Spd1 is degraded. In support of this
proposal, the p27 cyclin-dependent kinase inhibitor is an
IDP that mediates formation of immature inactive Cdk2–
CycA complexes (Russo et al. 1996). p27 folds onto the
Cdk2 and CycA subunits, both individually and at the
same time. Intriguingly, p27 directly inhibits Cdk2 by
altering the conformation of the catalytic cleft and insert-
ing a tyrosine residue as anATP-mimicking residue. In this
context, we note that, in active a2b2 tetramers, the R2
C-terminal residue is buried in a deep cleft of R1, and that
interference with optimal RNR complex architecture has
been observed using R2 C-terminal-mimicking peptides
(Cohen et al. 1986). It has also been suggested that the
C-terminal Phe of Sml1 (F104), which is mandatory for full
inhibition in S. cerevisiae (Zhao et al. 2000), may also
insert into the same deep cleft of R1 that is the binding
pocket for the C-terminal aromatic residue of the R2
subunit. The change in fluorescence emission also sup-
ports the involvement of tyrosines and/or tryptophans in
the interactions.
Once Spd1-dependent inactive complexes are formed,
we propose that Spd1 degradation would leave them in the
optimal conformation for catalytic activity by removing
the direct inhibition and allowing activation via ATP
binding to the allosteric ‘‘overall activity’’ site. To explain
why spd1-d cells never exhibit FRET butmaintain RNR in
an active form, we postulate that, in the absence of Spd1,
RNR complexes do still form, but with an alternative
suboptimal architecture. The fact that these are abundant
and not inhibited by Spd1 compensates for the loss of the
Spd1-dependent forms.
Conclusion
We showed that Spd1 acts as an import factor for Suc22R2,
as predicted from its relationship to Dif1 in S. cerevisiae.
Since it also functions to restrain RNR activity in vivo,
we asked if these two phenomena were related. Contrary
to our expectation, the assaysmeasuring restraint of RNR
activity in vivo did not correlate with Suc22R2 import,
demonstrating that the major function of Spd1 in regu-
lating dNTP synthesis is unrelated to its role in nuclear
sequestration of Suc22R2. We also established a FRET
assay that revealed a novel aspect of RNR behavior that
has the potential to provide yet another mechanism to
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regulate RNR, possibly through alterations of tetramer
architecture. The precise role for this new effect of Spd1
on RNR and how it relates to the regulation of RNR
awaits further analysis. The segmental distribution of
Spd1 functionality uncovered here is reminiscent of the
hallmarks of IDPs, including the association with multi-
ple partners. Thus, the IDP nature of Spd1 likely explains
how this small protein is able to regulate R1–R2 com-
plexes in multiple ways.
Materials and methods
Cloning, expression, stability, purification, and interactions
of recombinant proteins
The spd1, suc22, and cdc22 ORFs were PCR-amplified, cloned
into appropriate vectors, and verified by sequencing. Individual
spd1mutations were constructed using oligonucleotide-directed
mutagenesis, and each was verified by sequencing. Coupled in
vitro transcription–translation (Promega) was performed using
the manufacturer’s instructions to produce 35S-labeled protein.
Cell extracts were prepared by resuspending cell pellets in an
equal volume of HB buffer (25 mM Tris-HCl at pH 7.5, 15 mM
EGTA, 15 mM MgCl2 0.1% NP-40, 1 mM DTT, 0.1 mM NaF)
and grinding by mortar and pestle under liquid nitrogen, and
were clarified by 10-min centrifugation in a microfuge at 4°C. In
vitro degradation reactions were started by adding 35S-labeled
protein and were stopped after 10- or 20-min incubation at room
temperature by adding SDS sample buffer. Labeled protein was
visualized by SDS-PAGE and was quantified using a Storm
PhosphorImager. Expression and purification of Cdc22 and
Suc22 was as reported previously (Hakansson et al. 2006). For
expression of recombinant protein spd1+, ORF was ligated into
pET11a and expressed in BL21(DE3) (0.1 M IPTG). For pro-
duction of 15N-labeled protein, cells were grown in 1 L LB media
(100 mg/mL ampicillin) to OD600 0.7–0.8, harvested by centrifu-
gation (25 min at 2000g), resuspended in M9 media (100 mg/mL
ampicillin) with (15NH4)2SO4 (1.5 g/L) as the sole nitrogen
source, and grown for 1 h before induction. Induction was for 3
h at 37°C. Induced cells were harvested (15 min at 5000g);
resuspended in 25 mL of 13 PBS (140 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4), 25% (w/v) sucrose, 5 mM
EDTA, and 1% (w/v) Triton X-100; and sonicated three times
with intermediate washes in the same buffer. Spd1 was found in
the pellets, and this was dissolved in 50mL of 20mMTris (pH 8),
4.5 M urea, and 0.1% (v/v) Triton X-100, and spun 15 min at
20,000g. Supernatant was applied to a Mono Q column equili-
brated in buffer A (20 mM Tris at pH 8, 4.5 M urea, 0.1% [v/v]
Triton X-100) and eluted in a linear gradient of buffer B (20 mM
Tris at pH 8, 4.5M urea, 0.1% [v/v] Triton X-100, 1MNaCl). The
relevant fractions were identified and dialyzed extensively
against 13 PBS (pH 7.4) using a cut-off of 3000 g/mol. Protein
was concentrated and stored at 20°C until further use. Gel
filtration was performed by loading 2 mg total cross-linked
protein on a Superose 6 column following extraction of proteins
by grinding in liquid nitrogen. Cells were first incubated with 2
mM homobifunctional cross-linker SDP (Thermo Scientific) for
30 min. Log-phase cells were either treated or not with 20 mM
HU for 4 h. Interactions between Cdc22 or Suc22 with Spd1 were
assayed by fluorescence quenching spectroscopy using a Perkin-
Elmer LS50B and 1 mM protein concentrations alone or in
mixture in 10 mM sodium phosphate (pH 7.4). Excitation was
at 280 nm at room temperature, averaging five scans and
subtracting buffer backgrounds. Theoretical emission spectra
for the case of noninteracting proteins were generated by
addition of spectra recorded on individual proteins. To assay
dATP concentration, small molecule extracts were prepared
from 50-mL cultures growing in minimal medium and harvested
at 5.0 3 106 cells per milliliter on a 0.45-mm filter, washed once
in ice cold water, and resuspended in ice-cold 500-mL 20%TCA/
15 mM MgCl2. After three freeze–thaw cycles and final centri-
fugation, the supernatant was ether-extracted seven times to
remove TCA. ATP was measured indirectly using a luciferase-
based ATP determination kit from Biaffin GmbH and Co., KG,
according to instructions. dATP was determined by a primer
extension assay on a dA-specific template as described in Roy
et al. (1999). Extended products were quantified on a Storm
PhosphorImager.
Spectroscopy
A sample of 10 mM Spd1 was prepared in 10 mM NaH2PO4
adjusted to pH 7.4 using NaOH. A far-UV CD spectrum was
recorded at room temperature on a Jasco 810 spectropolarimeter
using a light path length of 1 mm. A total of five scans were
accumulated from 250 to 190 nm, and buffer background was
subtracted. Scanning speed was 20 nm/min, and data pitch was
0.1 nm. The resulting spectrum was smoothed using an FFT
filter supplied by the Jasco software. A 15N,1H-HSQC NMR
spectrum was recorded at 10°C on a Varian INOVA 750-MHz
(1H) spectrometer with 48 transients in the direct dimension and
400 increments in t1. The spectrum was transformed and
visualized using NMRPipe (Delaglio et al. 1995). The NMR
sample was 1mM 15N-Spd1 and 10mMNaH2PO4 (pH 7.4) in 300
mL, which was centrifuged for 5 min at 5000g and transferred to
a 5-mm Shigemi NMR tube.
Cell biology and genetics
Yeast strains were constructed using standard methods. spd1
mutants and genomic tagged constructs were created by PCR-
amplifying the desired ORF using primers with ;80-base-pair
(bp) homology with the sequences flanking the genomic ORF.
The resulting fragment was purified and transformed into an
spd1Tura4 strain where ura4+ had replaced the spd1 ORF.
Replacements were selected by growth on 5-FOA, tested by
PCR, and verified as correct by sequencing. To assay spore
formation, strains were incubated on malt extract agar plates
and incubated for 3 d at 25°C, and 200 U were assessed for
zygotes/asci with zero to four spores. dATP measurements were
performed on purified nucleotides by assessing ability to support
primer extension against dNTP standard controls. The dATP
level is calculated relative to ATP in the extract; i.e., the primer
extension assay was performed on extract volume equal to 75
nmol ATP, as determined by a luciferase-based assay.
For epifluorescence and indirect immunofluorescence, cells
were grown in log culture at 30°C (unless otherwise specified) in
supplemented yeast extract (YE) media with or without drug as
specified. For FRET analysis, cells were harvested, washed with
PBS, and air dried on the slide; a drop of mounting medium (50%
glycerol, 50%water) and a cover slip were added; and fluorescent
proteins were visualized using a laser scanning confocal micro-
scope (LSM 510, Zeiss). Photobleaching of the acceptor was
performed by scanning the 514-nm Argon laser across a specific
region of interest (ROI) within a cell (cytoplasm or nucleus).
Images were processed in ImageJ (NIH). To calculate FRET,
images were normalized and intensities were measured for the
ROI. IDA indicates intensity of the donor in the presence of
acceptor (prebleach), ID indicates intensity of the donor in the
absence of acceptor (post-bleach), and IAUTO indicates back-
ground intensity (autofluorescence of an untagged control). The
Spd1 inhibition of RNR
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FRET efficiency is expressed as a percentage: 1  [(IDA 
IAUTO.)/(ID  IAUTO.)] 3 100. We also verified FRET efficien-
cies using a dedicated ImageJ macro. Levels of complexed and
dissociated R1–R2 were unresolved in the present assay: Donor
intensities were not corrected for noninteracting R1–R2, render-
ing FRET efficiencies as a marker of subunit association a quan-
titative measure of R1–R2 complex concentration or donor–
acceptor proximity. Concomitant photobleaching of donor with
the acceptor is similarly not accounted for, resulting in negative
FRETefficiencies in the absence of R1–R2 interaction and a lower
estimate of FRET in cases of positive association.
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